Journal of Viral Hepatitis

Article	Citations
Issue Information	123
Issue Information	34
	28
Baseline Alpha‐Fetoprotein Elevation and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B: A Multicentre Cohort Study	27
Issue Information	24
Clinical Observational Study on HBV Reactivation After Direct‐Acting Antiviral Therapy in HCV /	23
Persistence of immunity against hepatitis A in Brazilian children vaccinated with a single dose of inactivated virus vaccine	22
240‐week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C	22
The role of serum sphingolipids as potential biomarkers of non‐response to direct acting antiviral therapy in chronic hepatitis C virus infection	21
Falling treatment uptake in the hepatitis C care cascade is a growing threat to achieving elimination	20
Investigating rates and risk factors for hepatitis C virus reinfection in people receiving antiviral treatment in England	20
Hepatitis E Infection in Immunocompromised Patients Previously Treated With Rituximab	20
International disease burden of acute viral hepatitis among adolescents and young adults: An observational study	20
Hepatitis A occurrence and outbreaks in Europe over the past two decades: A systematic review	19
Uptake of the Birth Dose HBV Vaccine and Associated Factors Among Children in Sub‐Saharan Africa: An Analysis Using Recent Demographic and Health Survey Data	19
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B	18
Hepatitis B Surface Antigen Loss and Improved Clinical Outcomes in US Individuals With Chronic Hepatitis B Virus Infection	18
Issue Information	17
A cross‐sectional study of hepatitis C prevalence and correlates among persons who inject drugs in rural and non‐rural communities	17
Infectivity of Hepatitis B Virus Surface Antigen‐Positive Plasma With Undetectable HBV‐DNA: Can HBsAg Screening Be Discontinued in Egyptian Blood Donors?	16
Trends and Socio‐Demographic Patterns of Hepatitis B Virus Hospitalisations in Poland: A 12‐Year Nationwide Analysis	16
Characterisation of People Living With Chronic Hepatitis B Virus Infection in England and Stratification by HBsAg Levels: A Cross‐Sectional Study	16
A Network Map of Intracellular Alpha‐Fetoprotein Signalling in Hepatocellular Carcinoma	15
TRPM2 regulates autophagy to participate in hepatitis B virus replication	15
Integration and the risk of liver cancer—Is there a real risk?	15

Evaluation of Blood Droplet Volumes on the Cobas Plasma Separation Card for HCV RNA Testing in Resource‐Limited Settings	14
Long‐Term Follow‐Up of Neuropsychiatric Symptoms After Sustained Virological Response to Interferon‐Free and Interferon‐Based Hepatitis C Virus Treatment	14
Contribution of alcohol use in HIV/hepatitis C virus co‐infection to all‐cause and cause‐specific mortality: A collaboration of cohort studies	14
Sex‐related difference analyses of efficacy and safety in clinical trials of direct‐acting antivirals to treat chronic HCV genotype 1 and 3 infections	14
Epidemiology and Outcomes of Hepatitis E Virus‐Associated Hospitalisations in the United States With a Focus on Pregnancy: A Nationwide Population Study, 1998–2020	13
Reversibility of acute‐on‐chronic liver failure syndrome in hepatitis B virus‐infected patients with and without prior decompensation	13
Issue Information	13
Elevation of S2‐bound α1‐acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma	13
Prevalence of Hepatitis B Among Migrants Living in High‐Income Countries With Low/Intermediate HBV Prevalence–A Systematic Review and Meta‐Analysis	13
Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome study	13
Serum HBV RNA is associated with liver fibrosis regression in HBeAg‐positive chronic hepatitis B patients treated with nucleos(t)ide analogues	12
Systematic Screening for Hepatitis B, C, and HIV and Linkage to Care in Patients With Mental Health Disorders Admitted to the Emergency Department	12
Strategies to increase primary care provider capacity for hepatitis C care: The California ECHO‐PLUS study	12
The changing epidemiology of delta hepatitis in Türkiye over three decades: A systematic review	12
	12
Issue Information	12
Baseline and on‐treatment HBcrAg levels as predictors of HBeAg seroconversion in chronic hepatitis B patients treated with antivirals	11
	11
Network‐basedstrategies to combatHCV: Examining social and spatial drivers of transmission amongPWIDin New Delhi	11
Sustainable and equivalent improvements in symptoms and functional well‐being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection:	11
Challenges of hepatitis B treatment in rural Sub‐Saharan Africa: Treatment initiation and outcomes from a public hospital‐based clinic in Kono, Sierra Leone	11
A declaration from people living with hepatitis B: A call for a whole person approach	11
Tenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: A systematic review and meta‐analysis	10
Clinical and histological features of patients with chronic hepatitis B virus infection in the grey zone	10
Universal HCV Screening in Hospitalised Patients in France: It Could Be a Good Option! The DEVICHO	10
Measuring stigma associated with hepatitis B virus infection in Sierra Leone: Validation of an abridged Berger HIV stigma scale	10
Hepatitis E prevalence and infection in solid‐organ transplant recipients in the United States	10
Interventions to Increase Hepatitis B Testing Uptake Amongst Detained Populations: A Systematic Review	10
Risk of drug‐induced liver injury in chronic hepatitis B and tuberculosis co‐infection: A systematic review and meta‐analysis	10
HCV hotline facilitates Hepatitis C elimination during the COVID‐19 pandemic	10
Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver‐related complications in patients with chronic hepatitis C receiving direct‐acting antiviral agents	10
Safe co‐administration of direct‐acting antivirals and direct oral anticoagulants among patients with hepatitis C virus infection: An international multicenter retrospective cohort study	10
Outcomes and Survival of Egyptian Patients With Hepatitis B–Related Hepatocellular Carcinoma: A Multicentre Retrospective Study	10
Viral hepatitis in pregnancy	9
	9
Challenges of an EMR‐Based Hospital Alert Program for Micro‐Elimination of Hepatitis C in Tertiary Referral Hospitals	9
Hepatitis D virus infection: Progress on the path toward disease control and cure	9
Epidemiological Burden of Hepatitis Delta Virus in the United States	9
An updated assessment of hepatitis delta prevalence among adults in Canada: A meta‐analysis	9
Mixed‐Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis	9
The role of treatment of hepatitis C with direct‐acting antiviral agents on glycaemic control in diabetic patients: An updated systematic review and meta‐analysis	9
Socioeconomic Deprivation Weighs Heavily on Liver Fibrosis and Mortality After Hepatitis C Cure (ANRS CO22 Hepather)	8
Prognostic value of genotyping in hepatocellular carcinoma: A systematic review	8
Performance of HCV core antigen and PCR testing in a predominantly genotype 3 population	8
Duration of Nucleos(t)ide Analogue Treatments in Patients With Chronic Hepatitis B Virus Infection in the United States	8
The Efficacy and Sustainability of an Implementation Intervention ( FOCUS Program) on Linkage to Hepatitis C Care Time at a Community Health Center i	8
Clinical and patient‐reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™	8
Hepatitis B Vaccination Uptake and Associated Factors in the United States Before Implementing Universal Vaccination: A Nationally‐Representative Study	8
Frequency, Severity and Impact of Pegylated Interferon Alpha–Associated Flares in Hepatitis D Infection	8
Associations Between Prior and Current Unhealthy Alcohol Use and Liver Morbidity Risk and Mortality Among Veterans With a History of Hepatitis C Who Have Achieved Sustained Virological Response	8

Does hepatitis delta virus have a preference for hepatitis B virus genotype? A systematic review of the literature	8
	7
The Impact of Ambient Temperature on HCC Risk in Patients With Chronic Hepatitis B	7
Hepatitis B e antigen and e antibody in a multi‐ethnic cohort of adult chronic hepatitis B virus patients followed at a single liver unit for a period of 20 years	7
Balancing Efficiency and Accuracy in Hepatitis C Rapid Antibody Testing: Insights From a Cluster Randomised Crossover Trial	7
The immune landscape in hepatitis delta virus infection—Still an open field	7
Impact of COVID‐19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs	7
Issue Information	7
A novel test and treat program for hepatitis C virus infection utilizing HCV core antigen testing, among police and general population, Islamabad, Pakistan, 2022	7
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon‐alfa	7
Universal versus targeted screening for HCV infection in pregnancy in a diverse, multi‐ethnic population: Universal screening is more comprehensive	7
Performance Evaluation of the Elecsys HCV Duo Immunoassay in the Public Healthcare Setting in Cape Town, South Africa	7
Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct‐acting antivirals	7
CHB patients with rtA181T‐mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes	7
Role of hepatitis B surface antibody in seroreversion of hepatitis B surface antigen in patients achieving hepatitis B surface antigen loss with pegylated interferon‐based therapy	7
Risk factors for hepatitis C virus infection at a large urban emergency department	7
MELD score < 18 rule out 28‐day ACLF development among inpatients with hepatitis B‐related previous compensated liver disease	7
Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis	7
Mortality and morbidity related to hepatitis C virus infection in hospitalized adults—A propensity score matched analysis	7
	7
Barriers and enablers to people‐centred viral hepatitis care in Vietnam and the Philippines: Results of a patient journey mapping study	7
Dynamic personalized prediction of the individual liver‐related risk after sustained viral response in HCV patients	7
A Qualitative Systematic Review of Barriers and Facilitators to Hepatitis B and C Programmes in Prisons	7
	7
Phase 1 study of safety and tolerability of an oral contraceptive containing low‐dose ethinyl oestradiol combined with glecaprevir/pibrentasvir treatment in healthy premenopausal women	7
Early clinical efficacy of pegylated interferon treatment in patients with different phases of chronic HBV infection: A real‐world analysis	6
	6
Issue Information	6
Severe acute hepatitis of unknown origin in children: Is it still a mystery? What role does adenovirus play?	6
Reply to ‘Assessing the hepatitis C epidemiology in Switzerland: It’s not that trivial’	6
Knowledge and Perceptions of Hepatitis B in Immigrant Populations: A Systematic Review and Thematic Synthesis of Qualitative Research	6
Cigarette Smoking Is Associated With Lower Chance of Hepatitis B Surface Antigen Seroclearance and Altered Host Immunity	6
Prevalence of hepatitis B virus (HBV) and latent tuberculosis co‐infection and risk of drug‐induced liver injury across two large HBV cohorts in the United	6
Identifying and Linking to Care and Treatment Persons With Hepatitis C Who Were Lost to Follow‐Up, Georgia 2023–2024	6
Hepatocytes and Hepatic Stellate Cells Carry Different Levels of DNA Damage due to Their Sensitivity to Oxidative Stress in Chronic Hepatitis B	6
	6
Prevalence of and Risk Factors for Liver Enzyme Elevation After Hepatitis C Virologic Cure	6
Outcomes of Assisted Reproductive Technology in Women With Hepatitis B Infection	6
Preferences and feasibility of long‐acting technologies for treatment of hepatitis C virus in low‐ and middle‐income countries: A survey of providers and policymakers	6
Issue Information	6
Recognisable Alcohol Use Significantly Increases the Risk of Adverse Outcomes in Patients With Hepatitis B Virus‐Related Cirrhosis	6
Association Between Indirect Bilirubin Percentage to Albumin Ratio and Outcome of Hepatitis B Related Acute on Chronic Liver Failure Treated With Artificial Liver Support System	6
The Delta Delta: Gaps in screening and patient assessment for hepatitis D virus infection	6
Sequence characterization of extracellular HBV RNA in patient plasma	6
Substance use and CD4/CD8 ratio in HIV/HCV co‐infected people receiving direct‐acting antiviral treatment (ANRS CO13 HEPAVIH)	6
Hepatitis Delta Coinfection Rates and All‐Cause Mortality Among Hepatitis B‐Infected Veterans in the USA	6
Screening rates for hepatitis B and C among low‐income US veterans: Data from the National Veteran Homeless and Other Poverty Experiences Study	6
MiRNome Profiling of Circulating Extracellular Vesicles in Patients With Chronic Hepatitis D Undergoing Pegylated Interferon Alpha Treatment	6
Comments on “Hepatitis B Virus ( HBV ) Treatment Eligibility in the UK : Retrospective Longitudina	6
Screening, Prevalence and Management of Chronic Viral Hepatitis C in Mental Health Setting: Towards the Eradication of A Forgotten Reservoir	5
A Programme of Hepatitis C Surveillance With Active Linkage to Care (HEAL) for Inpatients in Two Tertiary Hospitals in Jiangsu, China	5
Genetic substructure and host‐specific natural selection trend across vaccine‐candidate ORF‐2 capsid protein of hepatitis‐E virus	5
Long‐Term Persistence of Hepatitis A Virus Immunity in Healthcare Workers Upto 25 Years After Vaccination	5
Prevalence of hepatitis C among pregnant women in an Appalachian population	5
Outcomes of a 1‐Year Pilot Study Implementing Universal Hepatitis Delta Virus Testing Among Veterans With Chronic Hepatitis B	5
Changes in Serum Rheumatoid Factor Following Eradication of Hepatitis C Virus Infection With Interferon or Direct Antiviral Therapy	5
Persistence of antibodies 5 years after hepatitis B vaccination in preterm birth children: A retrospective cohort study using real‐world data	5
Hepatitis C prevalence and elimination planning in Pakistan, a bottom‐up approach accounting for provincial variation	5
Telemedicine for Low‐Barrier Hepatitis C Care in Rural Patients With Substance Use Disorders: Lessons From Taiwan	5
	5
Thrombospondin 2 as a Predictive Biomarker for HCC in Hepatitis C Patients: A Longitudinal Study Following DAA Therapy	5
Prevalence and Factors Associated With Hepatitis B Virus Infection in Tigray Region, Northern Ethiopia	5
Depletion of circ_0088046 suppressed cell growth and motility of hepatocellular carcinoma via circ_0088046‐miR‐1299‐RTKN2 ceRNA pathway	5
A morphometric analysis of hepatitis B subviral particles shows no correlation of filament proportion and length with clinical stage and genotype	5
	5
Hepatic Steatosis Inhibits Hepatitis B Virus Replication by Promoting miR ‐122‐5p‐ SOX4	5
Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B‐coinfected adults in care in the United States	4
Impact of treatment with direct‐acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co‐infected individuals	4
Impact of Non‐Alcoholic Fatty Liver Disease on the HBsAg Loss of Patients With Chronic Hepatitis B Treated in Pegylated Interferon Alpha	4
Testing to sustain hepatitis C elimination targets in people who inject drugs: A network‐based model	4
Impact of Universal Screening for HDV in HBV‐ Infected Patients on Chronic	4
Regarding the predictive role of CXCL16 in liver inflammation in chronic hepatitis B patients	4
Determining the frequency and characteristics of Hepatitis C reinfections in North East England	4
Hepatitis C active viremia over time in an ED‐based testing programme: Impact, disparities and surveillance tool	4
Efficacy and safety of pan‐genotypic sofosbuvir and velpatasvir in patients with hepatitis C and HIV coinfection on dolutegravir‐based antiretroviral therapy	4
Trends in Use of Direct‐Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016–2024	4
Issue Information	4
Issue Information	4
HBV pgRNA profiles in Chinese HIV/HBV coinfected patients under pre‐ and posttreatment: a multicentre observational cohort study	4
Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States	4

Time to Hepatitis C Care Engagement and Treatment Outcomes in Canadian Immigrants Have Markedly Improved Over Three Decades	4
Shear wave elastography: How well does it perform in chronic hepatitis D virus infection?	4
Hepatitis after gene therapy, what are the possible causes?	4
	4
Protective Role of Coffee in Chronic Liver Disease: A Focus on Processing	4
Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID‐19 pandemic	4
Reply to: ‘Abnormal liver function tests and coronavirus disease 2019: A close relationship’	4
Factors influencing compliance with Hepatitis C treatment in patients transitioning from prison to community—A summary scoping review	4
Assessing the hepatitis C epidemiology in Switzerland: It’s not that trivial	4
Chronic viral hepatitis C micro‐elimination program using telemedicine in Guigang city	4
Dynamic Changes in ELF Score Predict Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Antiviral Treatment	4
Towards hepatitis C elimination in France: Scanvir, an effective model to test and treat drug users on dedicated days	4
Substance use and CD4/CD8 ratio in HIV/HCV co‐infected people receiving direct‐acting antiviral treatment (ANRS CO13 HEPAVIH): Authors' reply	4
Cost‐Effectiveness of De Novo Combination of Tenofovir Alafenamide Fumarate and Peginterferon Alfa‐2b Versus Peginterferon Alfa‐2b Monotherapy of HBeAg	4
	4
Bulevirtide Monotherapy or in Combination for Chronic Hepatitis Delta: 2025 Update	4
A randomized phase 1b trial of the active site polymerase inhibitor nucleotide ATI‐2173 in patients with chronic hepatitis B virus infection	4
Test characteristics for combining non‐invasive liver fibrosis staging modalities in individuals with Hepatitis C virus	4
	4
Lower Serum Albumin Level: A Prospective Risk Predictor of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection	4
Demographic and Clinical Characteristics of Patients With Hepatitis C and Hepatitis B Co‐Infection, Georgia, 2017–2023	4